INDUKINE
Dead / Abandoned — Abandoned — failure to respond (as of 29 Dec 2022)
What this means for you
This application is over — abandoned 19 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88126403
- Mark type
- Stylized text
- Filed
- 21 Sept 2018
- Published for opposition
- 12 Feb 2019
- Abandoned
- 19 Dec 2022
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the field of cancer treatment and diagnosis; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Owner
- Werewolf Therapeutics, Inc., Cambridge, MA, US
- Werewolf Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 29 Dec 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 29 Dec 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 29 Dec 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 16 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jun 2022 — NON-FINAL ACTION E-MAILED
- 16 Jun 2022 — SU - NON-FINAL ACTION - WRITTEN
- 15 Jun 2022 — ASSIGNED TO EXAMINER
- 13 Apr 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Apr 2022 — USE AMENDMENT FILED
- 09 Apr 2022 — TEAS STATEMENT OF USE RECEIVED
- 15 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2021 — SOU EXTENSION 5 GRANTED
- 11 Oct 2021 — SOU EXTENSION 5 FILED
- 11 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 13 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED